34-20B-20. Depressants specifically included in Schedule III.
Any material, compound, mixture, or preparation is included in Schedule III that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
(1)Any substance that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances that are specifically listed in other schedules;
(2)Chloral betaine;
(3)Chloral hydrate;
(4)Chlorhexadol;
(5)Lysergic acid;
(6)Lysergic acid amide;
(7)Methyprylon;
(8)Sulfondiethylmethane;
(9)Sulfonethylmethane;
(10)Sulfonmethane;
(11)Amobarbital, pentobarbital, and secobarbital in suppository dosage form;
(12)Gamma hydroxy butyrate;
(13)Dronabinol in sesame oil and encapsulated in a gelatin capsule in a drug product approved for marketing by the United States Food and Drug Administration;
(14)Buprenorphine;
(15)Embutramide;
(16)Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile], including its salts, isomers, and salts of isomers.
Source: SL 1970, ch 229, §8 (c) (1); SDCL Supp, §39-17-63; SL 1973, ch 260; SL 1979, ch 238, §2; SL 1980, ch 240, §1; SL 1992, ch 245, §2; SL 1993, ch 247, §4; SL 1999, ch 174, §1; SL 2000, ch 170, §2; SL 2003, ch 183, §3; SL 2007, ch 194, §2, eff. Feb. 1, 2007; SL 2014, ch 165, §2, eff. Feb. 10, 2014; SL 2018, ch 203, §4, eff. Feb. 8, 2018.